Scope of the Report:

The worldwide market for Cardiac Biomarker is expected to grow at a CAGR of roughly over the next five years, will reach million US$ in 2024, from million US$ in 2019, according to a new study.

This report focuses on the Cardiac Biomarker in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers

Alere

Roche Diagnostics

BG Medicine

Biomerieux

Critical Diagnostics

DiaDexus

Response Biomedical

Siemens Healthcare

Singulex

Thermo Scientific

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia etc.)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Creatine kinase (CK) MB

Troponin (cTnI and cTnT)

BNP & NT-proBNP

Myogloblin

Others (hs-CRP, D-Dimer, etc.)

Market Segment by Applications, can be divided into

Myocardial Infarction

Congestive Heart Failure

Acute Coronary Syndrome

Atherosclerosis

Others

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Cardiac Biomarker product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top manufacturers of Cardiac Biomarker, with price, sales, revenue and global market share of Cardiac Biomarker in 2017 and 2018.

Chapter 3, the Cardiac Biomarker competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Cardiac Biomarker breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.

Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.

Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.

Chapter 12, Cardiac Biomarker market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.

Chapter 13, 14 and 15, to describe Cardiac Biomarker sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Table of Contents

1 Market Overview

1.1 Cardiac Biomarker Introduction

1.2 Market Analysis by Type

1.2.1 Creatine kinase (CK) MB

1.2.2 Troponin (cTnI and cTnT)

1.2.3 BNP & NT-proBNP

1.2.4 Myogloblin

1.2.5 Others (hs-CRP, D-Dimer, etc.)

1.3 Market Analysis by Applications

1.3.1 Myocardial Infarction

1.3.2 Congestive Heart Failure

1.3.3 Acute Coronary Syndrome

1.3.4 Atherosclerosis

1.3.5 Others

1.4 Market Analysis by Regions

1.4.1 North America (United States, Canada and Mexico)

1.4.1.1 United States Market States and Outlook (2014-2024)

1.4.1.2 Canada Market States and Outlook (2014-2024)

1.4.1.3 Mexico Market States and Outlook (2014-2024)

1.4.2 Europe (Germany, France, UK, Russia and Italy)

1.4.2.1 Germany Market States and Outlook (2014-2024)

1.4.2.2 France Market States and Outlook (2014-2024)

1.4.2.3 UK Market States and Outlook (2014-2024)

1.4.2.4 Russia Market States and Outlook (2014-2024)

1.4.2.5 Italy Market States and Outlook (2014-2024)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

1.4.3.1 China Market States and Outlook (2014-2024)

1.4.3.2 Japan Market States and Outlook (2014-2024)

1.4.3.3 Korea Market States and Outlook (2014-2024)

1.4.3.4 India Market States and Outlook (2014-2024)

1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)

1.4.4 South America, Middle East and Africa

1.4.4.1 Brazil Market States and Outlook (2014-2024)

1.4.4.2 Egypt Market States and Outlook (2014-2024)

1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)

1.4.4.4 South Africa Market States and Outlook (2014-2024)

1.4.4.5 Turkey Market States and Outlook (2014-2024)

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1 Alere

2.1.1 Business Overview

2.1.2 Cardiac Biomarker Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Alere Cardiac Biomarker Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.2 Roche Diagnostics

2.2.1 Business Overview

2.2.2 Cardiac Biomarker Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Roche Diagnostics Cardiac Biomarker Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.3 BG Medicine

2.3.1 Business Overview

2.3.2 Cardiac Biomarker Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 BG Medicine Cardiac Biomarker Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.4 Biomerieux

2.4.1 Business Overview

2.4.2 Cardiac Biomarker Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Biomerieux Cardiac Biomarker Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.5 Critical Diagnostics

2.5.1 Business Overview

2.5.2 Cardiac Biomarker Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Critical Diagnostics Cardiac Biomarker Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.6 DiaDexus

2.6.1 Business Overview

2.6.2 Cardiac Biomarker Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 DiaDexus Cardiac Biomarker Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.7 Response Biomedical

2.7.1 Business Overview

2.7.2 Cardiac Biomarker Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 Response Biomedical Cardiac Biomarker Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.8 Siemens Healthcare

2.8.1 Business Overview

2.8.2 Cardiac Biomarker Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 Siemens Healthcare Cardiac Biomarker Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.9 Singulex

2.9.1 Business Overview

2.9.2 Cardiac Biomarker Type and Applications

2.9.2.1 Product A

2.9.2.2 Product B

2.9.3 Singulex Cardiac Biomarker Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.10 Thermo Scientific

2.10.1 Business Overview

2.10.2 Cardiac Biomarker Type and Applications

2.10.2.1 Product A

2.10.2.2 Product B

2.10.3 Thermo Scientific Cardiac Biomarker Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

3 Global Cardiac Biomarker Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)

3.1 Global Cardiac Biomarker Sales and Market Share by Manufacturer (2017-2018)

3.2 Global Cardiac Biomarker Revenue and Market Share by Manufacturer (2017-2018)

3.3 Market Concentration Rate

3.3.1 Top 3 Cardiac Biomarker Manufacturer Market Share in 2018

3.3.2 Top 6 Cardiac Biomarker Manufacturer Market Share in 2018

3.4 Market Competition Trend

4 Global Cardiac Biomarker Market Analysis by Regions

4.1 Global Cardiac Biomarker Sales, Revenue and Market Share by Regions

4.1.1 Global Cardiac Biomarker Sales and Market Share by Regions (2014-2019)

4.1.2 Global Cardiac Biomarker Revenue and Market Share by Regions (2014-2019)

4.2 North America Cardiac Biomarker Sales and Growth Rate (2014-2019)

4.3 Europe Cardiac Biomarker Sales and Growth Rate (2014-2019)

4.4 Asia-Pacific Cardiac Biomarker Sales and Growth Rate (2014-2019)

4.5 South America Cardiac Biomarker Sales and Growth Rate (2014-2019)

4.6 Middle East and Africa Cardiac Biomarker Sales and Growth Rate (2014-2019)

5 North America Cardiac Biomarker by Country

5.1 North America Cardiac Biomarker Sales, Revenue and Market Share by Country

5.1.1 North America Cardiac Biomarker Sales and Market Share by Country (2014-2019)

5.1.2 North America Cardiac Biomarker Revenue and Market Share by Country (2014-2019)

5.2 United States Cardiac Biomarker Sales and Growth Rate (2014-2019)

5.3 Canada Cardiac Biomarker Sales and Growth Rate (2014-2019)

5.4 Mexico Cardiac Biomarker Sales and Growth Rate (2014-2019)

6 Europe Cardiac Biomarker by Country

6.1 Europe Cardiac Biomarker Sales, Revenue and Market Share by Country

6.1.1 Europe Cardiac Biomarker Sales and Market Share by Country (2014-2019)

6.1.2 Europe Cardiac Biomarker Revenue and Market Share by Country (2014-2019)

6.2 Germany Cardiac Biomarker Sales and Growth Rate (2014-2019)

6.3 UK Cardiac Biomarker Sales and Growth Rate (2014-2019)

6.4 France Cardiac Biomarker Sales and Growth Rate (2014-2019)

6.5 Russia Cardiac Biomarker Sales and Growth Rate (2014-2019)

6.6 Italy Cardiac Biomarker Sales and Growth Rate (2014-2019)

7 Asia-Pacific Cardiac Biomarker by Country

7.1 Asia-Pacific Cardiac Biomarker Sales, Revenue and Market Share by Country

7.1.1 Asia-Pacific Cardiac Biomarker Sales and Market Share by Country (2014-2019)

7.1.2 Asia-Pacific Cardiac Biomarker Revenue and Market Share by Country (2014-2019)

7.2 China Cardiac Biomarker Sales and Growth Rate (2014-2019)

7.3 Japan Cardiac Biomarker Sales and Growth Rate (2014-2019)

7.4 Korea Cardiac Biomarker Sales and Growth Rate (2014-2019)

7.5 India Cardiac Biomarker Sales and Growth Rate (2014-2019)

7.6 Southeast Asia Cardiac Biomarker Sales and Growth Rate (2014-2019)

8 South America Cardiac Biomarker by Country

8.1 South America Cardiac Biomarker Sales, Revenue and Market Share by Country

8.1.1 South America Cardiac Biomarker Sales and Market Share by Country (2014-2019)

8.1.2 South America Cardiac Biomarker Revenue and Market Share by Country (2014-2019)

8.2 Brazil Cardiac Biomarker Sales and Growth Rate (2014-2019)

8.3 Argentina Cardiac Biomarker Sales and Growth Rate (2014-2019)

8.4 Colombia Cardiac Biomarker Sales and Growth Rate (2014-2019)

9 Middle East and Africa Cardiac Biomarker by Countries

9.1 Middle East and Africa Cardiac Biomarker Sales, Revenue and Market Share by Country

9.1.1 Middle East and Africa Cardiac Biomarker Sales and Market Share by Country (2014-2019)

9.1.2 Middle East and Africa Cardiac Biomarker Revenue and Market Share by Country (2014-2019)

9.2 Saudi Arabia Cardiac Biomarker Sales and Growth Rate (2014-2019)

9.3 Turkey Cardiac Biomarker Sales and Growth Rate (2014-2019)

9.4 Egypt Cardiac Biomarker Sales and Growth Rate (2014-2019)

9.5 Nigeria Cardiac Biomarker Sales and Growth Rate (2014-2019)

9.6 South Africa Cardiac Biomarker Sales and Growth Rate (2014-2019)

10 Global Cardiac Biomarker Market Segment by Type

10.1 Global Cardiac Biomarker Sales, Revenue and Market Share by Type (2014-2019)

10.1.1 Global Cardiac Biomarker Sales and Market Share by Type (2014-2019)

10.1.2 Global Cardiac Biomarker Revenue and Market Share by Type (2014-2019)

10.2 Creatine kinase (CK) MB Sales Growth and Price

10.2.1 Global Creatine kinase (CK) MB Sales Growth (2014-2019)

10.2.2 Global Creatine kinase (CK) MB Price (2014-2019)

10.3 Troponin (cTnI and cTnT) Sales Growth and Price

10.3.1 Global Troponin (cTnI and cTnT) Sales Growth (2014-2019)

10.3.2 Global Troponin (cTnI and cTnT) Price (2014-2019)

10.4 BNP & NT-proBNP Sales Growth and Price

10.4.1 Global BNP & NT-proBNP Sales Growth (2014-2019)

10.4.2 Global BNP & NT-proBNP Price (2014-2019)

10.5 Myogloblin Sales Growth and Price

10.5.1 Global Myogloblin Sales Growth (2014-2019)

10.5.2 Global Myogloblin Price (2014-2019)

10.6 Others (hs-CRP, D-Dimer, etc.) Sales Growth and Price

10.6.1 Global Others (hs-CRP, D-Dimer, etc.) Sales Growth (2014-2019)

10.6.2 Global Others (hs-CRP, D-Dimer, etc.) Price (2014-2019)

11 Global Cardiac Biomarker Market Segment by Application

11.1 Global Cardiac Biomarker Sales Market Share by Application (2014-2019)

11.2 Myocardial Infarction Sales Growth (2014-2019)

11.3 Congestive Heart Failure Sales Growth (2014-2019)

11.4 Acute Coronary Syndrome Sales Growth (2014-2019)

11.5 Atherosclerosis Sales Growth (2014-2019)

11.6 Others Sales Growth (2014-2019)

12 Cardiac Biomarker Market Forecast (2019-2024)

12.1 Global Cardiac Biomarker Sales, Revenue and Growth Rate (2019-2024)

12.2 Cardiac Biomarker Market Forecast by Regions (2019-2024)

12.2.1 North America Cardiac Biomarker Market Forecast (2019-2024)

12.2.2 Europe Cardiac Biomarker Market Forecast (2019-2024)

12.2.3 Asia-Pacific Cardiac Biomarker Market Forecast (2019-2024)

12.2.4 South America Cardiac Biomarker Market Forecast (2019-2024)

12.2.5 Middle East and Africa Cardiac Biomarker Market Forecast (2019-2024)

12.3 Cardiac Biomarker Market Forecast by Type (2019-2024)

12.3.1 Global Cardiac Biomarker Sales Forecast by Type (2019-2024)

12.3.2 Global Cardiac Biomarker Market Share Forecast by Type (2019-2024)

12.4 Cardiac Biomarker Market Forecast by Application (2019-2024)

12.4.1 Global Cardiac Biomarker Sales Forecast by Application (2019-2024)

12.4.2 Global Cardiac Biomarker Market Share Forecast by Application (2019-2024)

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Future Trend

13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Data Source

List of Tables and Figures

Figure Cardiac Biomarker Picture

Table Product Specifications of Cardiac Biomarker

Figure Global Sales Market Share of Cardiac Biomarker by Types in 2018

Table